Literature DB >> 33896273

Visualization Ability of Phase-Contrast Synchrotron-Based X-Ray Imaging Using an X-Ray Interferometer in Soft Tissue Tumors.

Thet-Thet Lwin1,2, Akio Yoneyama3, Hiroko Maruyama1,2, Tohoru Takeda1,2.   

Abstract

Phase-contrast synchrotron-based X-ray imaging using an X-ray interferometer provides high sensitivity and high spatial resolution, and it has the ability to depict the fine morphological structures of biological soft tissues, including tumors. In this study, we quantitatively compared phase-contrast synchrotron-based X-ray computed tomography images and images of histopathological hematoxylin-eosin-stained sections of spontaneously occurring rat testicular tumors that contained different types of cells. The absolute densities measured on the phase-contrast synchrotron-based X-ray computed tomography images correlated well with the densities of the nuclear chromatin in the histological images, thereby demonstrating the ability of phase-contrast synchrotron-based X-ray imaging using an X-ray interferometer to reliably identify the characteristics of cancer cells within solid soft tissue tumors. In addition, 3-dimensional synchrotron-based phase-contrast X-ray computed tomography enables screening for different structures within tumors, such as solid, cystic, and fibrous tissues, and blood clots, from any direction and with a spatial resolution down to 26 μm. Thus, phase-contrast synchrotron-based X-ray imaging using an X-ray interferometer shows potential for being useful in preclinical cancer research by providing the ability to depict the characteristics of tumor cells and by offering 3-dimensional information capabilities.

Entities:  

Keywords:  X-ray interferometer; histopathological images; phase-contrast synchrotron-based X-ray imaging; rats; testicular tumors

Year:  2021        PMID: 33896273     DOI: 10.1177/15330338211010121

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  1 in total

1.  Spermatocytic tumor: A rare case report.

Authors:  Mei-Ling Hao; Chun-Hui Li
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.